Luping Huang
China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
MAL/SPP1 axis drives tumor proliferation and immune evasion via JAK2/STAT3 and MHC class Ib in breast cancer.
Journal: International immunopharmacology
Published: January 12, 2026
Tumor regression grade predicts recurrence-free survival in intermediate-advanced hepatocellular carcinoma after conversion therapy.
Journal: Frontiers in immunology
Published: September 12, 2025
Intermedin (adrenomedullin 2) plays a protective role in sepsis by regulating T- and B-cell proliferation and activity.
Journal: International immunopharmacology
Published: March 07, 2023
Intermedin (adrenomedullin 2) promotes breast cancer metastasis via Src/c-Myc-mediated ribosome production and protein translation.
Journal: Breast cancer research and treatment
Published: April 07, 2022
Inhibition of Intermedin (Adrenomedullin 2) Suppresses the Growth of Glioblastoma and Increases the Antitumor Activity of Temozolomide.
Journal: Molecular cancer therapeutics
Published: July 20, 2020
Sunitinib facilitates metastatic breast cancer spreading by inducing endothelial cell senescence.
Journal: Breast cancer research : BCR
Published: May 22, 2020
Multi-walled carbon nanotube carpets as scaffolds for U87MG glioblastoma multiforme cell growth.
Journal: Materials science & engineering. C, Materials for biological applications
Published: May 29, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026